UNSPSC 51182046: Roxibolone

This classification denotes an anabolic steroid with the molecular formula C21H28O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3R7NLP419C, chemically known as 11beta,17beta-dihydroxy-17-methyl-3-oxoandrosta-1,4-diene-2-carboxylic acid but generally known as roxibolone, which bears US NIH Compound Identifier 68795. European Medicines Agency schedules Roxibolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10397MIG.

UNSPSC 51182046 Roxibolone is a Commodity code that represents a specific pharmaceutical steroid compound. State and local government procurement under this code is minimal and highly specialized, limited primarily to corrections departments, mental health and substance abuse treatment agencies, and public health authorities that stock this medication for inmate or client populations. The work involves purchasing the pharmaceutical product itself rather than services; issuing bodies are corrections agencies, state departments of health, county detention facilities, and public health clinics. Roxibolone procurement is typically handled through established pharmaceutical supply contracts, cooperative purchasing vehicles, or standing agreements with licensed drug wholesalers rather than through competitive open solicitations.

No recent state or local contract opportunities under UNSPSC 51182046 appear in available records. The code shows no recent RFP, RFQ, IFB, or ITB activity that would indicate current competitive procurement activity at the state, county, municipal, school district, or transit authority level.